comparemela.com
Home
Live Updates
Diagnostic Segment - Breaking News
Pages:
Latest Breaking News On - Diagnostic segment - Page 1 : comparemela.com
Kepler Capital Sticks to Their Buy Rating for Grifols SA (GRFS)
In a report released on July 27, Pablo de Renteria from Kepler Capital maintained a Buy rating on Grifols SA (GRFS – Research Report), wi.
Comunidad autonoma de cataluna
Antonio grifols roig
Pablo de renteria
Kepler capital
Research report
Moderate buy
Bio supplies
Bioscience segment
Hospital segment
Diagnostic segment
Stevanato Group S p A : Stevanato Group Announces Second Quarter 2021 Financial Results
- Establishes Full Year 2021 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology
United states
Franco moro
Franco stevanato
Italian tax agency
York stock exchange
Company investor relations
Exchange commission
Development expenses
Stevanato group
New york stock exchange
Company quarterly report on form
Full year
Chief executive officer
Executive chairman
Diagnostic segment
Engineering segment
vimarsana © 2020. All Rights Reserved.